Is ACE gene polymorphism a useful marker for diabetic albuminuria in Japanese NIDDM patients?

Diabetes Care. 1996 Dec;19(12):1420-2. doi: 10.2337/diacare.19.12.1420.

Abstract

Objective: We studied the relationship between an insertion/deletion (I/D) polymorphism in the ACE gene and albuminuria/proteinuria in Japanese NIDDM patients.

Research design and methods: A total of 142 Japanese NIDDM patients (89 men, 53 women) with a known diabetes duration of 14 +/- 5 (mean +/- SD) years and an age of 56 +/- 6 years were divided into three groups according to the stage of nephropathy: 41 patients with normoalbuminuria, 47 patients with microalbuminuria, and 54 with overt proteinuria. The three groups were similar in age, diabetes duration, and recent HbAic level.

Results: The distribution of DD, ID, and II genotypes of the ACE gene did not differ among the three groups (10, 46, and 44% in the normoalbuminuric patients; 13, 53, and 34% in the microalbuminuric patients; and 15, 46, and 39% in the proteinuric patients, respectively). Meanwhile, the frequency of the D allele in the proteinuric male patients was slightly higher than in the normoalbuminuric male patients (45 vs. 27%, chi 2 = 3.9, P < 0.05), while the D allele frequency was nonsignificantly lower in the proteinuric female patients than in the normoalbuminuric female patients.

Conclusion: These results did not support the hypothesis that the genotype of the ACE gene would be a clinically useful genetic marker for predicting the development of nephropathy in Japanese NIDDM patients. However, the role of D allele of ACE gene in the progression of nephropathy in male patients remains to be seen.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Albuminuria*
  • Creatinine / blood
  • DNA Transposable Elements
  • Diabetes Mellitus, Type 2 / genetics*
  • Diabetes Mellitus, Type 2 / physiopathology*
  • Diabetes Mellitus, Type 2 / urine
  • Female
  • Genetic Markers*
  • Genotype
  • Glycated Hemoglobin / analysis
  • Humans
  • Japan
  • Male
  • Middle Aged
  • Peptidyl-Dipeptidase A / genetics*
  • Polymorphism, Genetic*
  • Sequence Deletion
  • Sex Characteristics

Substances

  • DNA Transposable Elements
  • Genetic Markers
  • Glycated Hemoglobin A
  • Creatinine
  • Peptidyl-Dipeptidase A